women's mental health - MGH Center for Women's Mental Health

Soy Supplements: No Effect on Cognition in Postmenopausal Women

Soy-based products have long been touted as a treatment for menopausal symptoms. However, many of the clinical studies measuring the effectiveness of dietary sources of soy isoflavones (e.g., soy beverages, soy powder) for the treatment of menopausal vasomotor symptoms (i.e., hot flushes, night sweats) have been negative. Less is known about the effects of soy on cognition. A large clinical trial suggests that soy may not have any positive effects on cognition in postmenopausal women.

By MGH Center for Women's Mental Health|2015-08-12T12:31:30-04:00July 18th, 2012|Alternative & Complementary, Cognition, Menopausal Symptoms, Treatment|Comments Off

Use of Antipsychotic Medications in Pregnancy Increases Risk of Gestational Diabetes

Atypical antipsychotic medications are commonly used for the treatment of schizophrenia and bipolar disorder. Despite the increasing use of these medications in women of child-bearing age, there is still relatively little data regarding the reproductive safety of these medications.

By Ruta Nonacs, MD PhD|2024-04-14T16:18:01-04:00July 17th, 2012|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Pregnancy Outcomes|Comments Off

Measuring the Effects of Antidepressants versus Untreated Depression on Pregnancy Outcomes

Multiple studies have demonstrated an increased risk of poor neonatal adaptation associated with exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants in late pregnancy. Results in the literature consistently indicate that about 25%-30% of infants exposed to SSRIs late in pregnancy manifest symptoms of poor neonatal adaption, including jitteriness, restlessness, increased muscle tone, rapid breathing. These symptoms are transient, resolving spontaneously with no specific medical intervention.

By MGH Center for Women's Mental Health|2015-08-12T13:56:55-04:00July 10th, 2012|Depressive Disorders, Outcomes, Psychiatric Disorders During Pregnancy|Comments Off

Acupuncture Helpful for Reducing Anxiety in Women Undergoing IVF

Most women undergoing infertility treatment experience increased anxiety. In a randomized clinical trial, researchers explored the effectiveness of acupuncture in diminishing anxiety in a group of women undergoing IVF. 43 patients undergoing IVF received either active acupuncture (n=22) or sham treatment (n=21). Women with a history of psychiatric illness and those using antidepressants and/or anxiolytic drugs were excluded from the study. Anxiety levels were assessed before and after treatment using the Hamilton Anxiety Rating Scale (HAS).

By MGH Center for Women's Mental Health|2015-08-12T13:58:40-04:00July 10th, 2012|Alternative & Complementary, Anxiety Disorders, Infertility and Mental Health, Psychiatric Disorders During Pregnancy, Treatment|Comments Off

A Simple Educational Intervention Reduces the Risk of Postpartum Intervention

While postpartum depression can affect all women, there are certain populations which appear to be at particularly high risk, including women of lower socioeconomic status. These women have limited access to resources and have multiple stressors including housing problems, financial strain, and being a single parent. Researchers recently piloted an intervention randomized controlled trial involving 540 participants at an inner-city hospital in East Harlem, New York. The primary goal of this psychoeducational intervention was to reduce the risk of postpartum depression among black and Latina mothers.

By MGH Center for Women's Mental Health|2015-08-12T14:08:04-04:00July 2nd, 2012|Postpartum Psychiatric Disorders, Prevention|Comments Off

Infertility Treatment is Stressful: But Does Stress Affect the Chances of Getting Pregnant?

It is common for women experiencing infertility and undergoing fertility treatment to experience significant emotional distress. Many women, reasoning that their emotional health influences their physical functioning, worry that the stress and anxiety they experience in this context may hinder their ability to become pregnant.

By MGH Center for Women's Mental Health|2015-08-12T14:26:09-04:00June 25th, 2012|Infertility and Mental Health, Outcomes, PTSD and Stress Related Disorders|Comments Off

In Brief: Menopausal Symptoms Usually Go Untreated

In this study, half of women aged 45 to 60 years reported experiencing menopausal symptoms. 69% of these women reported that their symptoms have negatively affected their lives. Among the women who endorsed menopausal symptoms, 72% had not received any treatment for their symptoms and 77% reported that they had not discussed treatment options with their healthcare providers.

By MGH Center for Women's Mental Health|2016-07-22T13:44:53-04:00June 18th, 2012|Depressive Disorders, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off

The Affordable Care Act: Improving Women’s Access to Health Care

One of the goals of the Affordable Care Act (ACA) is to improve women’s access to health care. In the past, women could be denied insurance coverage because they were women or could be charged more for insurance than their male counterparts.

By MGH Center for Women's Mental Health|2015-08-12T14:43:19-04:00June 8th, 2012|Advocacy, General|Comments Off

New Research from the CWMH: Progestins Do Not Negatively Affect Mood in Peri- and Postmenopausal Women

More than half of all women initiating treatment with hormone therapy will stop within the first year of treatment, most often because of side effects. Mood disturbance is a relatively common side effect that occurs with hormone therapy, and previous studies have suggested that progestins in the combined hormone preparations are responsible for these negative mood effects.

By MGH Center for Women's Mental Health|2016-03-28T13:02:53-04:00May 30th, 2012|Depressive Disorders, Hormone Therapy, Menopausal Symptoms, Prevalence & Risk Factors, Research at CWMH|Comments Off

PPHN and SSRIs: Yet Another Study

A few weeks after the FDA called into question the association between SSRI exposure and persistent pulmonary hypertension of the newborn or PPHN, BMJ published another article supporting an increased risk of PPHN among infants exposed to SSRIs in utero.

By MGH Center for Women's Mental Health|2015-08-12T16:58:14-04:00January 26th, 2012|Antidepressants, Child Outcomes, Neonatal Symptoms, Outcomes, Pregnancy & Medications|Comments Off

women’s mental health